While surgical excision is effective for localized tumours, the management of advanced melanoma has been revolutionized by targeted therapies, such as BRAF-MEK inhibitors, and by immune checkpoint inhibitors, which have significantly improved patient survival [[2], [3], [4]]. Here, BRAF is linked to melanoma.